Health Condition 1: null- Cardio vascular Diseases
Conditions
Interventions
Intervention1: SPREAD interventions group
: Participants in the SPREAD Intervention group will be followed up by trained health workers in addition to routine treating physicians care. Health workers
Sponsors
Department of Health Human Services
Eligibility
Inclusion criteria
Inclusion criteria: Consenting patients being discharged after an acute coronary event such as unstable angina, acute myocardial infarction, or after coronary intervention (CABG surgery or PCI).
Exclusion criteria
Exclusion criteria: Patients with other terminal/ debilitating illness, (e.g., advanced cancer, disabling stroke) those not expected to survive for the study duration, those with dementia and psychiatric illness or patients unlikely to comply with study requirements, including regular follow up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The two primary outcomes for the pilot study include 1. Feasibility (recruit 800 patients in 1 year, follow 95% of randomized patients, have the CHW administer the intervention at 90% of the planned visits) 2. Difference in adherence to CAD (Coronary Artery Diseases) medications (antiplatelet, beta blockers, ACE inhibitors, ARB, diuretics and statins) for secondary prevention compared to the control group, at one year.Timepoint: 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine the feasibility of conducting a secondary prevention trial on adherence to medications and lifestyle advice, and to obtain estimates of rates of adherence to pharmacotherapy and lifestyle modification interventions and the rates of major cardiovascular events. Timepoint: 12 Month | — |
Countries
India
Contacts
Public ContactDr Alben Sigamani
St.Johns Research Institute
Outcome results
None listed